The CARRA Registry for Pediatric Rheumatic Diseases
Full IRB Study Title:
Observational Study Of Pediatric Rheumatic Diseases: The CARRA Registry
IRB Study ID: 1167543-1
The CARRA Registry will help monitor the long term safety of current medications being used to treat pediatric rheumatic diseases. By collecting information from thousands of patients to evaluate their treatments, side effects and quality of life.
Study Sponsor:
Duke University
We are currently recruiting
If you are interested in this study or have questions about your child's eligibility, please contact:
Sherry Hillyer, Clinical Research Nurse: 330-543-5853
Jessica Kracker, Clinical Research Nurse: 330-543-0846
Who May Qualify:
Children and young adults with pediatric rheumatic disease from 2 to 21 years of age.
Who Does NOT Qualify:
Patients over 21 years of age.
Lead Investigator
Kathryn Cook, DO
Director, Division of Rheumatology; Pediatric Rheumatologist
Pediatric RheumatologyVasculitis Clinic
